17/18 January 2007 Wiener Neustadt - Czelo

More documents

Recommendations

Info

inhibition with minimal drug induced side effects. The Technology An essential component of the NovaCaps®- technology is a newly developed method for the encapsulation of genetically modified live human cells. AUSTRIANOVA has developed this encapsulation technology especially for the treatment of cancer. Research and Development AUSTRIANOVA’s encapsulation technology is an extremely versatile platform that can be applied in diverse areas: research projects currently in progress are focused on the genetic modification of cells to convert them into virus producing cells (ViroCaps®). It is planned to use the viruses (NovaVir®) produced from these cells as gene transfer systems, which are able to target additional tumour types and metastases. This will enable delivery of the therapeutic gene to the surrounding cancer cells thereby increasing the effect of the previous suicide gene mediated cancer cell killing effect. Proof of principle for this has already been shown (Saller, et al., Encapsulated cells producing retroviral vectors for in vivo gene transfer, J Gene Med 2002, 4, 150-160). For more detailed information see our website: http://www.austrianova.com/ 1. Profile: Reques Measurement and/or visualisation of nanomaterials and nanostructures in biological systems DESCRIPTION: We seek experts with technology to allow us to detect, visualise and/or measure nano- to micro-scaled biological or synthetic materials under biologically stable conditions. For example, we would like to take high resolution pictures of 50 - 150 nm sized magentic and/or flourescent particles attached to live retroviral vectors (80 - 120 nm) in order to be able to characterise the interaction. Also, we are very interested to visualise and capture the movement of micospheres or nano-propellors attached to the rotating subunit of the F1 ATPase biomolecular motor. INNOVATIVE ASPECTS: Working with state-of-the-art nanomaterials e.g. hybrid organic/inorganic NEMS MAIN ADVANTADGES / BENEFITS: Publication in scientific journal Potential for furture translational research TECHNICAL SPECIFICATIONS: Open CURRENT STAGE OF DEVELOPMEN Some aspects are ready for testing and some require further development INTELLECTUAL PROPERTY RIGHTS (IPR): Still collecting data in order to be able to apply for patent MARKET APPLICATIONS: human and animal cancer gene therapy basic and applied research with enveloped viruses TYPE OF COLLABORATION SOUGH We are open for all academic research collaborations, R&D projects or technology offers which will allow us to acheive our goals. PARTNER PROFILE: Open 2. Profile: Reques Measurement and/or visualisation of nanomaterials and nanostructures in biological systems DESCRIPTION: encapsulation of genetically modified or non-manipulated human or animal cells INNOVATIVE ASPECTS: world wide first GMP compliant cell encapsulation technology, allowing application of encapsulated live cells into human patients MAIN ADVANTADGES / BENEFITS: cells of choice can be placed in situ where required and are fully protected from the patients immune system due to pores in the capsules small molecules such as nutrients, activated metabolites, hormones etc. can pass into and out of the capsules and have contact with the encapsulated cells TECHNICAL SPECIFICATIONS:
Not relavent CURRENT STAGE OF DEVELOPMEN clinical phase III trials for human pancreatic cancer treatment INTELLECTUAL PROPERTY RIGHTS (IPR): Patent Granted MARKET APPLICATIONS: potentially very diverse medical applications e.g. treatment of all types of solid tumour based on current system, controlled release of hormones and antibodies, cells producing toxic or therapeutic factors TYPE OF COLLABORATION SOUGH research and development with novel cell types and diffusible factors PARTNER PROFILE: Open
Page 1: • Electronics, Microelectronics
Page 4 and 5: Organisation Index Institute of Phy
Page 6 and 7: Organisation Index TECHNICAL UNIVER
Page 8 and 9: Organisation Index Faculty of Mater
Page 10 and 11: 1. Profile: RTD: High sensitive wea
Page 12 and 13: New applications or new products re
Page 14 and 15: AMAG rolling GmbH Address Postfach
Page 16 and 17: Attophotonics Biosciences GmbH Addr
Page 18 and 19: austriamicrosystems Address Tobelba
Page 20 and 21: Austrian Researc Centers GmbH - ARC
Page 22 and 23: Austrian Research Centers GmbH - AR
Page 24 and 25: D. Swarovski & Co. Address Swarovsk
Page 26 and 27: FFG - EIP - Austrian EUREKA Office
Page 28 and 29: FFG Austrian Research Promotion Age
Page 30 and 31: FFG Austrian Research Promotion Age
Page 32 and 33: Happy Plating GmbH Address Leobersd
Page 34 and 35: Institute of Materials Science and
Page 36 and 37: INTELLECTUAL PROPERTY RIGHTS (IPR):
Page 40 and 41: Integrated Microsystems Austria Gmb
Page 42 and 43: Joanneum Research GmbH Address Stey
Page 44 and 45: Joanneum Research, Insitute of Nano
Page 46 and 47: Kunststoff-Cluster, Clusterland Obe
Page 48 and 49: M.Kaindl Flooring Address Kaindlstr
Page 50 and 51: CURRENT STAGE OF DEVELOPMEN plannin
Page 52 and 53: MAGNIFIN Magnesiaprodukte GmbH & Co
Page 54 and 55: Montanuniversität - Nanonet Styria
Page 56 and 57: Polymer Competence Center Leoben Gm
Page 58 and 59: 1. Profile: Expertise: Nanoimprint
Page 60 and 61: Psisys Ing.C.Vacariu Address Suchen
Page 62 and 63: state-of-the-art characterization m
Page 64 and 65: 1. Profile: Reques Electrochemical
Page 66 and 67: Sony DADC Austria AG Address Sonyst
Page 68 and 69: + Strategieentwicklung + Innovation
Page 70 and 71: Technology Consulting Centre TBZM A
Page 72 and 73: TU Wien and Austrian Center of Comp
Page 74 and 75: TU Wien- institute for solid state
Page 76 and 77: University of Linz Address Altenber
Page 78 and 79: University of Vienna, Department of
Page 80 and 81: Vienna University of Technology, In
Page 82 and 83: Zentrum für Mikro- und Nanostruktu
Page 84 and 85: INTELLECTUAL PROPERTY RIGHTS (IPR):
Page 86 and 87: market economy. The Technical Unive
Page 88 and 89:
Partner Qualification Criteria : Ex
Page 90 and 91:
Varna University of Medicine Addres
Page 92 and 93:
Brno University of Technology, Facu
Page 94 and 95:
CSNMT/nano section Address Novotneh
Page 96 and 97:
Fraunhofer IPA Address Nobelstraße
Page 98 and 99:
TECHNICAL SPECIFICATIONS: to be def
Page 100 and 101:
SURFACE systems + technology GmbH +
Page 102 and 103:
MTA MFA Address Konkoly-Thege u. 29
Page 104 and 105:
http://www.mfa.kfki.hu/eng/ Laborat
Page 106 and 107:
Research Institute for Solid State
Page 108 and 109:
ThalesNano Inc. Address Zahony utca
Page 110 and 111:
Materials Ireland Polymer Research
Page 112 and 113:
private reseacher Address Verchrats
Page 114 and 115:
film polymer foils with embedded mi
Page 116 and 117:
PUNJAB WATER SUPPLY AND SEWERAGE BO
Page 118 and 119:
Institute of Electron Technology Ad
Page 120 and 121:
Warsaw University of Technology, Fa
Page 122 and 123:
Wroclaw University of Technology, I
Page 124 and 125:
Fundação para a Ciência e a Tecn
Page 126 and 127:
METAV-RESEARCH DEVELOPMENT S.A. Add
Page 128 and 129:
NATIONAL INSTITUTE OF RESEARCH AND
Page 130 and 131:
-Joint research project PARTNER PRO
Page 132 and 133:
NATIONAL INSTITUTE OF RESEARCH AND
Page 134 and 135:
MARKET APPLICATIONS: The large appl
Page 136 and 137:
National R&D Institute for Microtec
Page 138 and 139:
MARKET APPLICATIONS: - Realisation
Page 140 and 141:
Production of individual structural
Page 142 and 143:
Faculty of Materials Science and Te
Page 144 and 145:
preparation INTELLECTUAL PROPERTY R
Page 146 and 147:
Nanoporous layers with 30-100nm cha
Page 148 and 149:
INKA - Institut für nanotechnische
Page 150 and 151:
INNOVATIVE ASPECTS: MAIN ADVANTADGE
Page 152:
2. Profile: Expertise: Plastic Elec
show all

17/18 January 2007 Wiener Neustadt - Czelo

Create successful ePaper yourself

Delete template?

Save as template?